
Scegli la tua etichetta
mostrata direttamente sul flaconcinoReta + Cagri Blend
GLP-1
- Spedito dalla Germania
Ordine
- DHL con tracciamento
- Imballaggio discreto
In sintesi
Reta + Cagri Blend in cifre
I dati chiave dalla nostra enciclopedia.
Voce completa dell'enciclopedia- Class
- Triple agonistGLP-1 / GIP / glucagon, + amylin analog
- Half-life
- Retatrutide around 6 dayscagrilintide around 7 to 8 days
- Form
- Lyophilisatepowder, reconstituted with BAC water
- Sizes
- 30 mg1 size in the shop
What studies show
All 5 sources in the lexicon- up to24.2 %Jastreboff et al., NEJM, 2023
- Sanyal et al., Nature Medicine, 2024
- Lau et al., The Lancet, 2021
Recensioni
Cosa dicono i clienti
Solo ordini reali che includevano Reta + Cagri Blend.
Tutte le recensioniNon esiste ancora un'analisi di laboratorio per Reta + Cagri Blend. Vota a favoreFallo testare tu, noi paghiamo la metàTutte le analisi di laboratorio
Conoscenze
Tutto su Reta + Cagri Blend
Informazioni dettagliate in arrivo.
Dosaggio
Caricamento informazioni sul dosaggio …
Utili da avere
Cosa ti serve insieme
L'acqua batteriostatica viene aggiunta automaticamente al carrello. Siringhe e tamponi con un clic.
Siringhe da insulina
10 pz · 5.50 €
Tamponi imbevuti di alcol
50 pz · 10 €
Quanta acqua?
Unità sulla siringa per la misura del tuo flaconcino.
Apri il calcolatore →Is the Reta + Cagri Blend approved or studied?
No. As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Retatrutide and cagrilintide together. Both components are in phase 3 and not approved.
Why Retatrutide and cagrilintide together?
Both act on different satiety pathways: Retatrutide on GLP-1, GIP and glucagon, cagrilintide on amylin receptors. With semaglutide as the partner, weight loss in a phase 1b trial after 20 weeks was 17.1 instead of 9.8 percent. For Retatrutide as the partner there are no data.
What do the studies of the components show?
Retatrutide alone: in TRIUMPH-1 after 80 weeks 25.0 percent less body weight on average at the highest study dose, 3.9 percent on placebo. Cagrilintide alone: up to 10.8 percent after 26 weeks in phase 2, 3.0 percent on placebo. In a substudy liver fat also fell sharply on Retatrutide.
Why is the cagrilintide share so small?
The vial contains five times as much Retatrutide as cagrilintide, because Retatrutide is the stronger and limiting part. Anyone going by the Retatrutide share stays far below the amounts used in the cagrilintide trials. Whether the small share contributes anything has not been studied.
How long do the components stay in the body?
Retatrutide had a half-life of about six days in a phase 1b study, cagrilintide 159 to 195 hours in another study, so about a week. Both fit one dose per week.
Which side effects were seen with the components?
With both, mainly gastrointestinal effects such as nausea and diarrhoea, depending on the dose. On Retatrutide heart rate rose in a dose-dependent way in phase 2. Two satiety signals together may strengthen nausea at the start, this has not been measured for this blend.
Which trials are still running?
Nine phase 3 trials of Retatrutide are running, the largest on heart and kidney events until 2029. The RENEW trials of cagrilintide alone run until 2027. No trial of the blend is listed in the registry.
Correlati
Prodotti correlati
Tirzepatide
Peptidi · GLP-1 e perdita di grasso GLP-1 e perdita di grasso
10 misure
Testato in laboratorio
= da 10 €/fiala
Retatrutide
Peptidi · GLP-1 e perdita di grasso GLP-1 e perdita di grasso
11 misure
Testato in laboratorio
= da 16 €/fiala
Semaglutide
Peptidi · GLP-1 e perdita di grasso GLP-1 e perdita di grasso
6 misure
Testato in laboratorio
= da 10 €/fiala
Mazdutide
Peptidi · GLP-1 e perdita di grasso GLP-1 e perdita di grasso
2 misure
= da 32 €/fiala
Reta + Cagri Blend